ALLO-316

· Allogene Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALLO-316, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma [Phase 1]